Hot Press News
- Future Electronics Singapore Townhall Meeting and Sharing 2024
- Sonata Unveils Its Vibrant Spring & Summer 2024 Collection with Poze
- Crescent City's May 10-11 Auction will Feature Property from The Dufour-Plassan House in New Orleans
- YPO Mumbai Connect Explores Business and Culture in Seoul, South Korea
- Career Mosaic Launches UG India Tour 2024: Connecting Indian Students with Global Education Opportunities
- QSG and Dr Agravat Healthcare Ltd Celebrates Oral Cancer Awareness April Month 2024 in India
- VerSe Innovation adds World's Largest Digital Newsstand to its portfolio; onboards 8,500+ premium magazines and newspapers
- To Increase Crop Yields, Central Biotech Introduces Novel Chemical Pesticides
- RX Japan's J AGRI Spotlights Kyushu's Potential as a Global Livestock Farming Hub
- Energy Infrastructure for EV Charging Stations Market Size, Report, Forecast to 2029
- Taggd Certified as a Great Place to Work in India
- DopeBoo Announces 20% to 40% Off on CBD Products and Glass Accessories For 4/20 Sale
- RI DUI Lawyer Expertise Expanded at John Grasso Law, Offering Unparalleled Defense Strategies
- NTN1 Protein: Unraveling the Role of Netrin-1 in Neural Development and Beyond
- Catch Spices, a core brand of Dharampal Satyapal Group, enters the INR 1000 Cr Club
SII | TAU develops genome editing system to destroy cancer cells
Video Description
1091
In a recent study, researchers at Tel Aviv University (TAU) have demonstrated that the CRISPR/Cas9 system is very effective in treating metastatic cancers- a significant step on the way to finding a cure for cancer. Funded by ICRF (Israel Cancer Research Fund), the results of the groundbreaking study, were published in November 2020 in Science Advances.
Company :-Good Relations India
User :- Uday Singh
Email :-uday.singh@gri.co.in
Mobile:- 9582180149
Advertisement
Get your Explainer Video at 100 dollars only Today.
To ensure stability and reachability of your applications at all times, remote DDoS protection can keep your hosting services online
